Author Page for Sanja Vidojkovic

Sanja Vidojkovic

Bavarian Nordic GmbH

Germany

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

A Randomized Phase 3 Trial to Assess the Immunogenicity and Safety of 3 Consecutively Produced Lots of Freeze-Dried MVA‑BN® Vaccine in Healthy Adults

Number of pages: 35 Posted: 12 May 2022

Edgar Turner Overton, Darja Schmidt, Sanja Vidojkovic, Erika Menius, Katrin Nopora, Jane Maclennan and Heinz Weidenthaler

University of Alabama at Birmingham, Bavarian Nordic GmbH, Bavarian Nordic GmbH, Bavarian Nordic, Inc., Bavarian Nordic GmbH, Bavarian Nordic A/S and Bavarian Nordic GmbH

Downloads 92 (730,864)

View PDF
Download

Sanja Vidojkovic

Bavarian Nordic GmbH

1

92

0

Scholarly Papers (1)

A Randomized Phase 3 Trial to Assess the Immunogenicity and Safety of 3 Consecutively Produced Lots of Freeze-Dried MVA‑BN® Vaccine in Healthy Adults

Abstract: